Evidence map›Paper›PMID 30427898›Full record

ArticlePloS one2018

Protein Disulfide Isomerase (PDI1-1) differential expression and modification in Mexican malting barley cultivars.

Jorge Herrera-Díaz, Mariela K Jelezova, Felipe Cruz-García, Tzvetanka D Dinkova

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jorge Herrera-DíazUnidad de Servicios de Apoyo a la Investigación y la Industria, Facultad de Química, Universidad Nacional Autónoma de México, Ciudad de México, México.
Mariela K JelezovaDepartamento de Bioquímica, Facultad de Química, Universidad Nacional Autónoma de México, Ciudad de México, México.ORCID 0000-0002-9137-3114
Felipe Cruz-GarcíaDepartamento de Bioquímica, Facultad de Química, Universidad Nacional Autónoma de México, Ciudad de México, México.
Tzvetanka D DinkovaDepartamento de Bioquímica, Facultad de Química, Universidad Nacional Autónoma de México, Ciudad de México, México.ORCID 0000-0001-7971-525X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Barley malting quality depends on seed characteristics achieved during grain development and germination. One important parameter is protein accumulation in the mature seed, which may vary between cultivars. Here we conducted a protein pattern analysis in the range of pI 4-7 of mature grains from five Mexican barley cultivars, commonly used for malt and beer production. Reproducibly distinct protein spots, separated by 2D SDS PAGE, were identified by mass spectrometry and considered as potential markers for cultivars with distinct seed protein accumulation. The expression patterns of glutamate decarboxylase (GAD) and protein disulfide isomerase (PDI1-1) were followed at transcript level during grain development for three independent growth cycles to establish whether differences between cultivars were reproducible. Quantitative determination of PDI1-1 protein levels by ELISA confirmed a reproducibly, distinctive accumulation and post-translational modifications between cultivars, which were independent of plant growth regimes. According to its impact on differential storage protein accumulation, we propose the PDI1-1 protein as potential biomarker for Mexican malting barley cultivars.

Indexed as

Gene Expression Regulation, PlantProtein Processing, Post-TranslationalGlycosylationHordeumProtein Disulfide-IsomerasesRNA, MessengerSeedsProtein Disulfide-IsomerasesRNA, Messenger

Identifiers

PMID30427898
PMCPMC6235301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.